Jacobi Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-750
| Closed | -$56K | – | 1047 |
|
|
2021
Q3 | $56K | Hold |
750
| – | – | 0.01% | 631 |
|
|
2021
Q2 | $58K | Hold |
750
| – | – | 0.01% | 592 |
|
|
2021
Q1 | $55K | Hold |
750
| – | – | 0.01% | 555 |
|
|
2020
Q4 | $53K | Buy |
750
+150
| +25% | +$10.6K | 0.01% | 526 |
|
|
2020
Q3 | $34K | Hold |
600
| – | – | 0.01% | 562 |
|
|
2020
Q2 | $35K | Sell |
600
-200
| -25% | -$11.7K | 0.01% | 537 |
|
|
2020
Q1 | $37K | Hold |
800
| – | – | 0.01% | 476 |
|
|
2019
Q4 | $45K | Hold |
800
| – | – | 0.01% | 486 |
|
|
2019
Q3 | $38K | Hold |
800
| – | – | 0.01% | 492 |
|
|
2019
Q2 | $43K | Hold |
800
| – | – | 0.01% | 477 |
|
|
2019
Q1 | $44K | Sell |
800
-400
| -33% | -$22K | 0.01% | 434 |
|
|
2018
Q4 | $56K | Hold |
1,200
| – | – | 0.02% | 372 |
|
|
2018
Q3 | $71K | Hold |
1,200
| – | – | 0.02% | 369 |
|
|
2018
Q2 | $66K | Hold |
1,200
| – | – | 0.02% | 374 |
|
|
2018
Q1 | $57K | Hold |
1,200
| – | – | 0.02% | 372 |
|
|
2017
Q4 | $58K | Hold |
1,200
| – | – | 0.02% | 346 |
|
|
2017
Q3 | $60K | Hold |
1,200
| – | – | 0.02% | 315 |
|
|
2017
Q2 | $55K | Hold |
1,200
| – | – | 0.02% | 292 |
|
|
2017
Q1 | $49K | Buy |
1,200
+400
| +50% | +$16.3K | 0.03% | 242 |
|
|
2016
Q4 | $32K | Sell |
800
-400
| -33% | -$16K | 0.02% | 270 |
|
|
2016
Q3 | $50K | Buy |
1,200
+400
| +50% | +$16.7K | 0.02% | 234 |
|
|
2016
Q2 | $31K | Buy |
+800
| New | +$31K | 0.02% | 296 |
|